Asia Pacific Acute Respiratory Disease Diagnostics Market Size & Outlook
Related Markets
Asia Pacific acute respiratory disease diagnostics market highlights
- The Asia Pacific acute respiratory disease diagnostics market generated a revenue of USD 1,350.4 million in 2024.
- The market is expected to grow at a CAGR of 8.7% from 2025 to 2033.
- In terms of segment, molecular diagnostics was the largest revenue generating test in 2024.
- Syndromic Respiratory Panels is the most lucrative test segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2033.
Asia Pacific data book summary
| Market revenue in 2024 | USD 1,350.4 million |
| Market revenue in 2033 | USD 3,018.7 million |
| Growth rate | 8.7% (CAGR from 2025 to 2033) |
| Largest segment | Molecular diagnostics |
| Fastest growing segment | Syndromic Respiratory Panels |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Molecular Diagnostics, Antigen-based Rapid Tests, Serological Tests (IgM/IgG), Syndromic Respiratory Panels, Other Emerging Technologies (CRISPR-based, Nanopore Sequencing, AI-driven Imaging) |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 24.6% of the global acute respiratory disease diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,018.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Acute Respiratory Disease Diagnostics Market Scope
Acute Respiratory Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| No records found. | ||||
Asia Pacific acute respiratory disease diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to acute respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Molecular diagnostics was the largest segment with a revenue share of 54.31% in 2024. Horizon Databook has segmented the Asia Pacific acute respiratory disease diagnostics market based on molecular diagnostics, antigen-based rapid tests, serological tests (igm/igg), syndromic respiratory panels, other emerging technologies (crispr-based, nanopore sequencing, ai-driven imaging) covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Asia Pacific acute respiratory disease diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific acute respiratory disease diagnostics market databook
-
Our clientele includes a mix of acute respiratory disease diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific acute respiratory disease diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific acute respiratory disease diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific acute respiratory disease diagnostics market size, by country, 2021-2033 (US$M)
Asia Pacific Acute Respiratory Disease Diagnostics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
